Cefuroxime And Dextrose Injection, Solution
Product Images NDC 0264-3114

This is a pharmaceutical product description for Cefuraxime for Injection USP with Dextrose Injection USP. The container is a 50mL DUPLEX® CONTAINER and requires mixing of both chambers before use. The reconstituted solution contains 1.5 g of Cefuraxime and approximately 145 g of Hydrous Dextrose USP in Water for Injection USP. The approximate osmolality is 290 mOsmolfkg. The product must be stored at 20-25°C (68-77°F) and protected from light until use. The prepared solution should be clear and free from particulate matter and must be used within 24 hours at room temperature or within 7 days if stored under refrigeration. The container is not made with natural rubber latex, PVC or DEHP, and is for Rx only.*

This is a drug chamber which has instructions to peel the foil strip only at the time of use and discard it if it is damaged. It is advised to inspect the drug before reconstitution. The package insert has complete directions for reconstitution and administration.*

This is a description of Cefl 750, which is a medication that comes in a 50mL container. The medication is a sterile, pyrogen-free solution that contains 750mg of ceuroamal. The instructions explain how to activate the chambers of the container, and recommend that the product be used within 7 days of reconstitution. The description provides approximate molarity and storage information. However, the text is not entirely clear, and some parts are not readable.*

This text is a set of instructions for a drug chamber product. It provides precautions to be taken while using the product and advises to discard the chamber if the foil strip is damaged. The user is advised to reconstitute the drug only when ready for use and after visually inspecting it. There is a reference made to a package insert for complete directions for reconstitution and administration.*